Metabolic & Longevity Peptides: Research Applications

A Category United by Metabolic Research Questions

This category groups compounds studied for their roles in cellular energy metabolism, mitochondrial signaling, and metabolic disease research — three distinct molecules connected by a shared research thread rather than a shared origin or mechanism.

Three Distinct Research Angles

MOTS-c is a mitochondrial-derived peptide, encoded directly within mitochondrial DNA rather than the nuclear genome. Research has focused on its activation of AMPK signaling and its relationship to insulin sensitivity and exercise-response physiology, positioning it as a research tool for studying mitochondrial-nuclear communication.

NAD+ is not a peptide but a dinucleotide coenzyme central to cellular redox chemistry and to sirtuin/PARP enzyme activity. Because NAD+ levels decline with age across multiple tissues, it is one of the most heavily studied molecules in preclinical aging and metabolic research, and is included in this catalog given its relevance to the same research programs as our peptide products.

Retatrutide is a synthetic triple receptor agonist (GIP/GLP-1/glucagon), representing the current frontier of incretin-pathway research for metabolic regulation, energy expenditure, and body composition — studied in both preclinical models and published clinical trial research.

Common Research Questions

Across this category, researchers commonly investigate:

• How cellular energy status (ATP/AMP ratio, NAD+/NADH ratio) is sensed and signaled between mitochondria, cytoplasm, and nucleus
• The relationship between metabolic hormone receptor engagement (incretin receptors) and systemic energy balance
• Aging-associated decline in metabolic efficiency and potential research targets for intervention

Related Reading

See the individual product pages for MOTS-c, NAD+, and Retatrutide for full specification data and references. For general handling guidance, see Storage & Handling.

This article summarizes published preclinical and clinical research literature. It does not constitute dosing or administration guidance. Peptide Factory products are supplied for research use only — not for human consumption.